Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Calvo

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The Journal of Clinical Investigation|June 18, 2024
Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in miceCharanya Muralidharan, Fei Huang, Jacob R Enriquez, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in MiceCharanya Muralidharan, Fei Huang, Jacob R Enriquez, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The Journal of Clinical Investigation|June 18, 2024
Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in miceCharanya Muralidharan, Fei Huang, Jacob R Enriquez, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in MiceCharanya Muralidharan, Fei Huang, Jacob R Enriquez, et al.
Pageof 2